Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

277 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
Seeber A, Binder M, Steiner A, Wolff K, Pehamberger H. Seeber A, et al. Eur J Cancer. 1998 Dec;34(13):2129-31. doi: 10.1016/s0959-8049(98)00316-5. Eur J Cancer. 1998. PMID: 10070323
We report on the clinical efficacy of a new sequential administration regimen with dacarbazine at a dose of 200 mg/m2 followed 24 h later by fotemustine 100 mg/m2 every 4 weeks in 63 patients with metastatic melanoma. ...
We report on the clinical efficacy of a new sequential administration regimen with dacarbazine at a dose of 200 mg/m2 followed 24 h l …
Trends in the diagnosis of melanoma at a university center over time.
Tschandl P, Pehamberger H, Kittler H. Tschandl P, et al. J Dtsch Dermatol Ges. 2013 Mar;11(3):251-6. doi: 10.1111/j.1610-0387.2012.08043.x. Epub 2012 Oct 19. J Dtsch Dermatol Ges. 2013. PMID: 23078407
Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice.
Schlagbauer-Wadl H, Klosner G, Heere-Ress E, Waltering S, Moll I, Wolff K, Pehamberger H, Jansen B. Schlagbauer-Wadl H, et al. J Invest Dermatol. 2000 Apr;114(4):725-30. doi: 10.1046/j.1523-1747.2000.00937.x. J Invest Dermatol. 2000. PMID: 10733680
[Tumor stem cell research - basis and challenge for diagnosis and therapy].
Karlic H, Herrmann H, Schulenburg A, Grunt TW, Laffer S, Mirkina I, Hubmann R, Shehata M, Marian B, Selzer E, Pfeilstöcker M, Pittermann E, Jäger U, Pehamberger H, Zielinski C, Valent P. Karlic H, et al. Wien Klin Wochenschr. 2010 Jul;122(13-14):423-36. doi: 10.1007/s00508-010-1408-z. Epub 2010 Jul 22. Wien Klin Wochenschr. 2010. PMID: 20645015 Review. German.
[Treatment of metastatic malignant melanoma (author's transl)].
Kühböck J, Pehamberger H, Mach K, Diem E, Kokoschka EM, Pötzi P. Kühböck J, et al. Wien Klin Wochenschr. 1978 Dec 22;90(24):856-8. Wien Klin Wochenschr. 1978. PMID: 84441 Clinical Trial. German.
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.
Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos A, Pehamberger H, Eggermont A. Garbe C, et al. Eur J Cancer. 2010 Jan;46(2):270-83. doi: 10.1016/j.ejca.2009.10.032. Epub 2009 Dec 1. Eur J Cancer. 2010. PMID: 19959353
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG; Oblimersen Melanoma Study Group. Bedikian AY, et al. J Clin Oncol. 2006 Oct 10;24(29):4738-45. doi: 10.1200/JCO.2006.06.0483. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966688 Clinical Trial.
Who benefits most from adjuvant interferon treatment for melanoma?
Gogas H, Abali H, Ascierto PA, Demidov L, Pehamberger H, Robert C, Schachter J, Eggermont AM, Hauschild A, Espinosa E. Gogas H, et al. Am J Ther. 2015 Jan-Feb;22(1):54-60. doi: 10.1097/MJT.0b013e31829e883d. Am J Ther. 2015. PMID: 24176884 Review.
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.
Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Bastholt L, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos AJ, Pehamberger H, Eggermont AM; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organisation for Research and Treatment of Cancer (EORTC). Garbe C, et al. Among authors: pehamberger h. Eur J Cancer. 2016 Aug;63:201-17. doi: 10.1016/j.ejca.2016.05.005. Epub 2016 Jun 29. Eur J Cancer. 2016. PMID: 27367293
277 results
Jump to page
Feedback